US Patent:
20020061932, May 23, 2002
Inventors:
Alberto Gimona - Basel, CH
Richard Macerata - Summit NJ, US
Jasper Huels - Huningue, FR
Eimear Nic Lochlainn - Dublin, IE
Argeris Karabelas - Princeton NJ, US
Simon Bateman - Randolph NJ, US
Jurij Holinej - Hackettstown NJ, US
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
Victor Sloan - Scotch Plains NJ, US
Sumedha Jayawardene - Bridgewater NJ, US
International Classification:
A61K031/195
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2′-chloro-6′fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, and compositions suitable for use in such methods.